Nathalia Idelevitch, MD
Geriatric Medicine · Brooklyn, NYNPI 1447440029
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,707 and has fallen 64.5% since, to $606 in 2025. Among geriatric medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $27.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$998
- Amgen$854
- AbbVie$584
- Lilly USA, LLC$529
- Aimmune Therapeutics, Inc.$411
- Novartis$283
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,329100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 32 | $998 |
| Amgen(2 entities) | 32 | $854 |
| AbbVie | 19 | $584 |
| Lilly USA, LLC | 22 | $529 |
| Aimmune Therapeutics, Inc. | 4 | $411 |
| Novartis | 14 | $283 |
| Corcept Therapeutics | 4 | $181 |
| Amarin Pharma, Inc. | 9 | $177 |
| Dexcom, Inc. | 1 | $125 |
| EMD Serono, Inc. | 1 | $125 |
| Vivus LLC | 5 | $90 |
| Nestle Healthcare Nutrition Inc. | 4 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $76 |
| Boehringer Ingelheim | 4 | $72 |
| Astellas Pharma US Inc | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Pfizer | 3 | $63 |
| Medtronic | 2 | $55 |
| Shield Therapeutics Inc | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Abbott | 2 | $45 |
| Endo Pharmaceuticals Inc. | 2 | $43 |
| Intra-sana Laboratories | 2 | $42 |
| AstraZeneca | 2 | $40 |
| Novo Nordisk | 2 | $39 |
| Merck | 2 | $28 |
| Ironwood Pharmaceuticals, Inc | 1 | $25 |
| Gilead | 1 | $23 |
| Radius Health, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Bayer | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$316
- ANORO$233
- Otezla$150
- DEXCOM G6 TRANSMITTER$125
- BAVENCIO$125
- MOUNJARO$125
- Korlym$125
- TRELEGY ELLIPTA$120
How this compares
$5,329 in reported general payments places this provider in the 90th percentile of 400 geriatric medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZenpepLipase/Protease/Amylase | 71 | $173,808 |
| CreonLipase/Protease/Amylase | 42 | $77,277 |
| LinzessLinaclotide | 98 | $55,622 |
| ProliaDenosumab | 33 | $53,067 |
| VascepaIcosapent Ethyl | 142 | $51,339 |
| EliquisApixaban | 75 | $51,267 |
| Diclofenac Sodium | 200 | $37,936 |
| OzempicSemaglutide | 26 | $28,425 |
| MyrbetriqMirabegron | 66 | $27,902 |
| MounjaroTirzepatide | 21 | $21,879 |
| TrintellixVortioxetine Hydrobromide | 30 | $14,703 |
| Icosapent Ethyl | 104 | $13,519 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 25 | $12,092 |
| Dexlansoprazole DrDexlansoprazole | 71 | $10,848 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 33 | $9,170 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Aimmune Therapeutics, Inc.Zenpep | $411 | $173,80871 claims |
| AbbVieCreon, Linzess, Atelvia | $584 | $136,043152 claims |
| AmgenProlia | $854 | $53,06733 claims |
| PfizerEliquis | $63 | $51,26775 claims |
| Novo NordiskOzempic | $39 | $28,42526 claims |
| Astellas Pharma US IncMyrbetriq | $70 | $27,90266 claims |
| GSKAnoro Ellipta, Breo Ellipta, Arnuity Ellipta | $998 | $23,73559 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Dexilant | $66 | $22,56356 claims |
| Lilly USA, LLCMounjaro | $529 | $21,87921 claims |
| Boehringer IngelheimJardiance, Tradjenta | $72 | $14,28524 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $76 | $6,56212 claims |
| AstraZenecaSymbicort | $40 | $5,73324 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 400 geriatric medicine providers in New York.
Other geriatric medicine in Brooklyn
- Wen DombrowskiBrooklyn$45K
- Inna ShifrinBrooklyn$21K
- Sergey GenkinBrooklyn$10K
- Diana LevinaBrooklyn$9K
- Faina KoganBrooklyn$7K
- William PutmanBrooklyn$6K
- Roberto RobinsonBrooklyn$6K
- Stefano FrancoBrooklyn$3K
- Larissa GoldBrooklyn$3K
- Howard OrkinBrooklyn$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.